Literature DB >> 2820062

Somatostatinomas, PPomas, neurotensinomas.

A I Vinik, W E Strodel, F E Eckhauser, A R Moattari, R Lloyd.   

Abstract

We have reviewed data pertinent to three tumor syndromes that derive from overproduction of three GEP peptide hormones. The clinical syndrome of somatostatin excess remains well defined with diabetes, diarrhea, steatorrhea being predominant features. With the availability of assays and increasing awareness, more cases are being diagnosed in the intestine and these differ somewhat in their presentation with cholecystitis, GI bleeding, or a mass as the cardinal features. An unusual association with MEN II pheochromacytoma and neurofibromatosis is emerging. PPomas remain enigmatic. Although diarrhea is a feature, these tumors are usually silent and present with hypatomegally, abdominal pain, and jaundice because of the large size and malignant nature. Neurotensinomas remain rare and truly difficult to separate from the symptom complex produced by VIP excess. Edema, hypotension, cyanosis and flushing should alert one to the possibility of a neurotensin-secreting tumor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820062

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  16 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

Review 2.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

3.  Pancreatic and peripancreatic somatostatinomas.

Authors:  J M L Williamson; C C Thorn; D Spalding; R C N Williamson
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

4.  Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.

Authors:  A F Hofmann
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.

Authors:  Zhengping Zhuang; Chunzhang Yang; Felipe Lorenzo; Maria Merino; Tito Fojo; Electron Kebebew; Vera Popovic; Constantine A Stratakis; Josef T Prchal; Karel Pacak
Journal:  N Engl J Med       Date:  2012-09-06       Impact factor: 91.245

6.  Incidental small ampullary somatostatinoma treated with ampullectomy 2 years after diagnosis.

Authors:  G Guercioni; C Marmorale; W Siquini; M Fianchini; A Fianchini; E Landi
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 7.  Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe
Journal:  Pancreas       Date:  2014-05       Impact factor: 3.327

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

9.  Surgical management of malignant islet cell tumors.

Authors:  C S Grant
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

Review 10.  Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas.

Authors:  Samuel C L Kuo; Sivakumar Gananadha; Christopher J Scarlett; Anthony Gill; Ross C Smith
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.